Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
As of 2022, the prevalence of Alzheimer’s disease (AD) among individuals aged 65 and older is estimated to be 6.2 million in the United States. This figure is predicted to grow to 13.8 million by 2060. An accurate assessment of neuropathologic changes represents a critical step in understanding the...
Main Authors: | Nicholas Doher, Vahid Davoudi, Shino Magaki, Ryan A. Townley, Mohammad Haeri, Harry V. Vinters |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.mdpi.com/2035-8377/15/3/54 |
Similar Items
-
Neurodegeneration: 2022 update
by: John Fonda Crary
Published: (2022-05-01) -
Neurodegeneration: 2023 update
by: John Fonda Crary
Published: (2023-09-01) -
The Neuropathological Diagnosis of Alzheimer’s Disease—The Challenges of Pathological Mimics and Concomitant Pathology
by: Andrew King, et al.
Published: (2020-07-01) -
Cognitive resilience and severe Alzheimer’s disease neuropathology
by: Narges Ahangari, et al.
Published: (2023-01-01) -
Update on Alzheimer’s Disease
by: Kurt A. Jellinger
Published: (2015-08-01)